JPRN-UMIN000010018已完成未知
Antiemetic effectiveness and safety of aprepitant in patients with lung cancer receiving combination therapy with carboplatin. - Antiemetic effectiveness of aprepitant in patients recieving combination therapy with carboplatin
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe complications. Patients with nausea and vomitting in the 24 hours before chemotherapy. Patients received antiemetic therapy in the 48 hours before chemotherapy. Patients with a risk of vomitting for other reasons. (active peptic ulcer and gastrointestinal obstruction, etc)
研究者
相似试验
已完成
2 期
The efficacy and safety of antiemetic therapy for carboplatin-containing chemotherapy-induced nausea and vomiting in patients with lung cancer.advanced lung cancerJPRN-UMIN000026739Second Division, Department of Internal Medicine, Hamamatsu university school of medicine30
已完成
2 期
Evaluation of anti-emetic efficacy of Aprepitant in patients undergo hematopoitic stem cell transplantation in a teaching hospitalCondition 1: Autologous bone marrow transplantation. Condition 2: emesis.Other transplanted organ and tissue statusHaematemesisIRCT201107026930N1Vice chancellor for research, Shahid Beheshti University of Medical Sciences80
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
Assesmentt of the efficacy of antiemetics for post procedure sedation vomiting (PPSV) in ED pediatric patientsSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0000370Ajou University270
进行中（未招募）
1 期
Efficacy and safety of aprepitant for vaso-occlusive crisis in sickle cell childvaso-occlusive crisis for patients with sickle cell diseaseMedDRA version: 20.0Level: LLTClassification code 10040644Term: Sickle cell diseaseSystem Organ Class: 100000004850EUCTR2019-000839-21-FRCentre Hospitalier Intercommunal de Créteil60